Understanding polydrug use: review of heroin and cocaine co-use.
about
Efficacy of Psychostimulant Drugs for Cocaine DependenceCocaine and kidney injury: a kaleidoscope of pathologySystematic review of prenatal cocaine exposure and adolescent developmentNew developments in the pharmacotherapy of cocaine abuseDissociated grey matter changes with prolonged addiction and extended abstinence in cocaine usersTrends of people using drugs and opioid substitute treatment recorded in England and wales general practice (1994-2012)Molecular Epidemiology of HIV-1 Infection among Men who Have Sex with Men in Taiwan in 2012A unified framework for addiction: vulnerabilities in the decision processPatterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherenceComparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, ChinaDopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.Disrupted iron regulation in the brain and periphery in cocaine addictionAsymmetric generalization and interaction profiles in rhesus monkeys discriminating intravenous cocaine or intravenous heroin from vehicle.Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study.Protracted withdrawal from cocaine self-administration flips the switch on 5-HT(1B) receptor modulation of cocaine abuse-related behaviorsThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Wide variation in the multiplicity of HIV-1 infection among injection drug usersUse of synthetic cathinones and cannabimimetics among injection drug users in San Diego, CaliforniaCOMBINING DIFFERENT SUBSTANCES IN THE DANCE SCENE: ENHANCING PLEASURE, MANAGING RISK AND TIMING EFFECTSCognitive performance profiles by latent classes of drug use.Drug specificity in drug versus food choice in male rats.Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusersRisk factors for criminal recidivism - a prospective follow-up study in prisoners with substance abuseProbability and predictors of the cannabis gateway effect: a national studyStandard magnitude prize reinforcers can be as efficacious as larger magnitude reinforcers in cocaine-dependent methadone patients.Low efficacy of non-opioid drugs in opioid withdrawal symptoms.Speedball induced changes in electrically stimulated dopamine overflow in rat nucleus accumbens.Heroin and cocaine co-use in a group of injection drug users in Montréal.A TYPOLOGY OF DRUG-RELATED OFFENDING AMONG YOUNG HOMELESS INJECTION DRUG USERS.The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Self-administration of cocaine and remifentanil by monkeys under concurrent-access conditionsCigarette smoking and short-term addiction treatment outcome.The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.Self-administration of cocaine and remifentanil by monkeys: choice between single drugs and mixturesDrug use patterns in the presence of crack in downtown MontréalUnderstanding subtypes of inner-city drug users with a latent class approachThe growing popularity of prescription opioid injection in downtown Montréal: new challenges for harm reduction.A typology of prescription drug misuse: a latent class approach to differences and harms.Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network.
P2860
Q24239994-0283D9B1-30D4-4367-9288-2E7DB079A734Q26829642-2CD3A215-BF8B-4E67-A725-3213A27AFDEEQ26998102-63C52477-D821-412A-8782-34022F72511CQ28302782-435C6643-00E1-4431-8074-8BB26CCBC8FCQ28488152-A8AFBE70-A8BE-45F9-A129-CAAC31595BCAQ28546846-51B06C9B-C401-4AC5-8034-3116EA6F22F8Q28547813-8AEDD501-A453-4A3C-9E1C-07676C40AD7FQ28680729-7E0DDC36-B5C8-4DF1-B003-60A00A1BEBA4Q33637963-3ADF6BD8-DAE3-443C-8080-F1BC9970A75CQ33668115-23196292-8B3A-4EFF-A404-9DEEF3490B1DQ33697312-79BA3CA6-1391-4C64-99E9-1AB562743C5FQ33707674-283D19B1-09C6-4F14-823A-FD0B9E19E71BQ33714902-6599B5D3-88B5-4AA4-A013-0EEFC5208711Q33750900-EBA6CD48-2927-4ABE-90A2-9C0EFD5281AAQ33809092-3D75BEF6-C5F0-4990-92C9-D51FFD65905FQ33870389-C7682691-5842-41BB-BC2B-9B84F7F8D27FQ33877419-73FA9DD0-9C6B-41C1-822F-C2EE1BF60310Q33968846-2CB683C1-93A7-4A61-B258-B1680D97710BQ34033958-1833A443-30F6-4814-B956-E177A3AB4E99Q34071049-AE91A6F6-1956-4828-A1B4-297859095AE6Q34141953-2AE233A4-262E-4067-A46C-78D39F1ADC37Q34300251-D67B380A-5D8F-4E3D-90D5-453D852E3BF9Q34380661-A39364A0-D80C-4CCF-8731-CA74EDE3CCCEQ34435738-D575E3B0-89D7-4B43-9B57-548792457548Q34437363-D99C7BA9-369F-4799-94B3-4B435DC15D97Q34454969-A0D2B443-44C6-4EAB-8396-1E19EA8217B3Q34459087-921892EB-D06F-4B01-BC73-DC8D695AA724Q34642369-67E4399A-2A4B-4042-9B34-90EC33D440A2Q34687167-2943932D-5C9B-49C9-9006-C4D5B00877C8Q34731327-AA6E4438-DD85-4363-A0B0-B360A2069677Q34749978-919C2270-EB4F-421D-A484-7948CA0AF90CQ34777406-FF18C2AB-1D97-44F2-8F41-E8C908842B07Q34827624-6818F551-786F-4405-8637-3CA9705A8F24Q35023292-FC4D8E12-7F55-4445-A7A3-DCDF86A541A6Q35024262-2DB5CC7C-C8D1-463A-8A7B-8D2014309EBCQ35106232-8111C7C5-8CEB-49E8-9708-2454DAF44A20Q35156798-00DCE8A1-8108-4336-B0C9-394112E7779BQ35179636-7E6E01E3-8B27-4A89-B52F-41A8821233E1Q35185972-23C6EF25-5FD2-4526-92B2-19128A7ECF8FQ35206845-22C716B3-C9B3-4C8B-BE3A-2D8CEF023A60
P2860
Understanding polydrug use: review of heroin and cocaine co-use.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Understanding polydrug use: review of heroin and cocaine co-use.
@ast
Understanding polydrug use: review of heroin and cocaine co-use.
@en
type
label
Understanding polydrug use: review of heroin and cocaine co-use.
@ast
Understanding polydrug use: review of heroin and cocaine co-use.
@en
prefLabel
Understanding polydrug use: review of heroin and cocaine co-use.
@ast
Understanding polydrug use: review of heroin and cocaine co-use.
@en
P2093
P2860
P1433
P1476
Understanding polydrug use: review of heroin and cocaine co-use.
@en
P2093
Francesco Leri
Jane Stewart
Julie Bruneau
P2860
P356
10.1046/J.1360-0443.2003.00236.X
P407
P577
2003-01-01T00:00:00Z